Prestige Brands Holdings—which touts a diverse product range with brands such as Dramamine motion sickness medication, Comet household cleaners and E.P.T. pregnancy tests—says second quarter revenues increased 13.7% over the prior year period to a record $206.1 million, including the impact of foreign currency fluctuations. Fiscal first half year revenues were up 21.8% to $398.2 million.

Reported revenues for the second quarter of fiscal 2016 increased 13.7% to $206.1 million. Reported revenues for the six-month period ended Sept. 30, 2015 jumped 21.8% to $398.2 million.

The results of both the fiscal second quarter and six-month periods reflect continued strong consumption levels across the company’s core over-the-counter healthcare brands and continued growth in the international business, as well as contributions from the acquisitions of Insight Pharmaceuticals and Hydralyte.